Semaglutide After Catheter Ablation: A New Chapter in Atrial Fibrillation Care?
- 1 November 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (11) , e014508
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Semaglutide Modulates Proinflammatory Epicardial Adipogenesis With Paracrine Effects on hiPSC-Atrial CardiomyocytesJACC: Basic To Translational Science, 2025
- Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysisAdvances in Therapy, 2024
- Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter AblationJACC: Clinical Electrophysiology, 2024
- Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesNew England Journal of Medicine, 2023
- Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial FibrillationJAMA Cardiology, 2023
- Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significanceCardiovascular Research, 2022
- Bariatric surgery to aLleviate OCcurrence of Atrial Fibrillation Hospitalization—BLOC-AFHeart Rhythm O2, 2020
- Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese SubjectsJACC, 2016
- Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation CohortJACC, 2015
- Relation of Proinflammatory Activity of Epicardial Adipose Tissue to the Occurrence of Atrial FibrillationThe American Journal of Cardiology, 2014